Evidence map›Paper›PMID 38648352›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2024

Genomic epidemiology of SARS-CoV-2 δ sublineages of the second wave of 2021 in Antioquia, Colombia

Cristian Arbey Velarde, Uriel Hurtado, Andres Fernando Cardona Rios, Celeny Ortiz, Idabely Betancur

Abstract readEnglish Abstract
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cristian Arbey VelardeLaboratorio Departamental de Salud Pública de Antioquia, Secretaría Seccional de Salud y Protección Social de Antioquia, Medellín, Colombia.ORCID 0000-0002-5350-1832
Uriel HurtadoCorporación para Investigaciones Biológicas, Medellín, Colombia.ORCID 0000-0002-9201-3014
Andres Fernando Cardona RiosLaboratorio Genómico One Health, Universidad Nacional, Medellín, Colombia.ORCID 0000-0002-2125-5809
Celeny OrtizDirección de Salud Colectiva, Secretaria de Salud de Antioquia, Secretaría Seccional de Salud de Antioquia, Medellín, Colombia.ORCID 0000-0001-7663-9167
Idabely BetancurLaboratorio Departamental de Salud Pública de Antioquia, Secretaría Seccional de Salud y Protección Social de Antioquia, Medellín, Colombia.ORCID 0000-0002-2193-5011

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. During the development of the SARS-CoV-2 pandemic in Antioquia, we experienced epidemiological peaks related to the α, ɣ, β, ƛ, and δ variants. δ had the highest incidence and prevalence. This lineage is of concern due to its clinical manifestations and epidemiological characteristics. A total of 253 δ sublineages have been reported in the PANGOLIN database. The sublineage identification through genomic analysis has made it possible to trace their evolution and propagation. Objective. To characterize the genetic diversity of the different SARS-CoV-2 δ sublineages in Antioquia and to describe its prevalence. Materials and methods. We collected sociodemographic information from 2,675 samples, and obtained 1,115 genomes from the GISAID database between July 12th, 2021, and January 18th, 2022. From the analyzed genomes, 515 were selected because of their high coverage values (>90%) to perform phylogenetic analysis and to infer allele frequencies of mutations of interest. Results. We characterized 24 sublineages. The most prevalent was AY.25. Mutations of interest as L452R, P681R, and P681H were identified in this sublineage, comprising a frequency close to 0.99. Conclusions. This study identified that the AY.25 sublineage has a transmission advantage compared to the other δ sublineages. This attribute may be related to the presence of the L452R and P681R mutations associated in other studies with higher evasion of the immune system and less efficacy of drugs against SARS-CoV-2.

Indexed as

COVID-19Genome, ViralPhylogenySARS-CoV-2AdolescentAdultAgedColombiaFemaleGene FrequencyGenetic VariationHumansMaleMiddle AgedMutationPandemicsClinical correlationsepidemiologyFunctional analysesGenetic modifiersgenomic sequencingMutationMyotoniaMyotonic disordersnucleotide sequencephylogenetic treepublic health surveillanceSARS-CoV-2

Identifiers

PMID38648352
PMCPMC11189595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.